Summary
The time course of the effects of isoprenaline (3 × 10−7 mol/l) on contractile force and on the cyclic AMP level was studied in the electrically driven isolated muscle strip of the human right atrium. Isoprenaline produced a rise in cyclic AMP content (maximum increase after 60 s) preceding the increase in contractile force. The effects of isoprenaline on contractile force and on the intracellular level of cyclic AMP were enhanced in the presence of the phosphodiesterase inhibitor papaverine (10−5 mol/l). On the other hand, the β-adrenoceptor antagonist propranolol (10−7 mol/l) suppressed isoprenaline-induced cyclic AMP increases, but reduced the increase in force of contraction by only 35%. In addition, both the β1-selective antagonist bisoprolol (3 × 10−9 × 10−8 mol/l) and the β2-selective antagonist ICI 118,551 (3 × 10−9 × 10−8 mol/l) inhibited the isoprenaline-induced cyclic AMP increase concentration-dependently; ICI 118,551 produced more pronounced inhibition than bisoprolol. It is concluded that cyclic AMP is involved in the positive inotropic action of isoprenaline evoked by β1- and β2-adrenoceptor stimulation in isolated human right atrium; however, an additional cyclic AMP independent mechanism cannot be ruled out.
Similar content being viewed by others
References
Ask JA, Stene-Larsen G, Helle KB, Resch F (1985) Functional β1and β2-adrenoceptors in the human myocardium. Acta Physiol Scand 123:81–88
Bilski AJ, Halliday SE, Fitzgerald JD, Wale JL (1983) The pharmacology of a β2-selective adrenoceptor antagonist (ICI 118,551). J Cardiovasc Pharmacol 5:430–437
Brodde O-E (1986) Bisoprolol (EMD 33,512), a highly selective β1 -adrenoceptor antagonist: in vitro and in vivo studies. J Cardiovasc Pharmacol 8 (Suppl 11):529–835
Brodde O-E, Motomura S, Endoh M, Schümann HJ (1978) Lack of correlation between the positive inotropic effect evoked by α-adrenoceptor stimulation and the levels of cyclic AMP and/or cyclic GMP in the isolated ventricle strip of the rabbit. J Mol Cell Cardiol 10:207–219
Brodde O-E, Schümann HJ, Wagner J (1980) Decreased responsiveness of the adenylate cyclase system on left atria from hypothyroid rats. Mol Pharmacol 17:180–186
Brodde O-E, Karad K, Zerkowski H-R, Rohm N, Reiderneister JChr (1982) Demonstration of β1- and β2-adrenoceptors in human heart by 125iodocyanopindolol binding. Naunyn-Schmiedeberg's Arch Pharmacol 321:(Suppl) R242
Brodde O-E, Karad K, Zerkowski H-R, Rohm N, Reidemeister JChr (1983) Coexistence of β1- and β2-adrenoceptors in human right atrium. Direct identification by (±)-125iodocyanopindolol binding. Circ Res 53:752–758
Brodde O-E, O'Hara N, Zerkowski H-R, Rohm N (1984) Human cardiac β-adrenoceptors are functionally coupled to the adenylate cyclase in right atrium. J Cardiovasc Pharmacol 6:1184–1191
Endoh M, Brodde O-E, Schumann HJ (1975) Accumulation of cAMP and positive inotropic effect evoked by isoproterenol under the graded inhibition of phosphodiesterase by papaverine in the isolated rabbit papillary muscle. J Mol Cell Cardiol 7:703–711
Gille E, Lemoine H, Ehle B, Kaaumann AJ (1985) The affinity of (−)-propranolol for β1- and β2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (−)-noradrenaline and (−)-adrenaline. Naunyn-Schmiedeberg's Arch Pharmacol 331:60–70
Gilman AG (1970) A protein binding assay for adenosine 3′,5′-cyclic monophosphate. Proc Natl Acad Sci USA 67: 305–312
Golf S, Hansson V (1986) Relative potencies of various β-adrenoceptor antagonists (BAA) at the level of the human myocardial β-adrenoceptor-adenylate cyclase (AC) complex. Is intrinsic sympathomimetic activity (ISA) due to AC activation? Scand J Clin Lab Invest 46:121–130
Golf S, Lovstadt R, Hansson V (1985) β-Adrenoceptor density and relative number of β-adrenoceptor subtypes in biopsies from human right atrial, left ventricular and right ventricular myocard. Cardiovasc Res 19:636–641
Hedberg A, Mattson H (1981) Beta adrenoceptor interaction of full and partial agonists in the cat heart and soleus muscle. J Pharmacol Exp Ther 219:798–808
Hedberg A, Kempf F, Josephson ME, Molinoff PB (1985) Coexistence of beta-1 and beta-2 adrenergic receptors in the human heart: effects of treatment with receptor antagonists or calcium entry blockers. J Pharmacol Exp Ther 234:561–568
Ingebretsen WR, Jr., Becker E, Friedman WIT, Mayer SE (1977) Contractile and biochemical responses of cardiac and skeletal muscle to isoproterenol covalently linked to glass beads. Circ Res 40:474–484
Kaumann AJ (1978) On spare β-adrenoceptors for isotropic effects of catecholamines in kitten ventricle. Naunyn-Schmiedeberg's Arch Pharmacol 305:97–102
Kaumann AJ, Lemoine H (1985) Direct labelling of myocardial β1-adrenoceptors. Comparison of binding affinity of 3H-(−)-bisoprolol with its blocking potency. Naunyn-Schmiedeberg's Arch Pharmacol 331:27–39
Kaumann AJ, Lemoine H, Morris TH, Schwederski U (1982) An initial characterization of human heart β-adrenoceptors and their mediation of the positive isotropic effects of catecholamines. Naunyn-Schmiedeberg's Arch Pharmacol 319:216–221
Lemoine H, Ehle B, Kaumann AJ (1985) Direct labelling of β2-adrenoceptors. Comparison of binding potency of 3H-ICI 118,551 and blocking potency of ICI 118,551. Naunyn-Schmiedeberg's Arch Pharmacol 331:40–51
Michel MC, Wang XL, Daul A, Brodde gnO-E (1987) β-Adrenoceptor antagonists with intrinsic sympathomimetic activity down-regulate human lymphocyte β-adrenoceptor density, but do not activate the lymphocyte cyclic AMP system. J Cardiovasc Pharmacol (in press)
Neve KA, Barret DA, Molinoff PB (1985) Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists. J Pharmacol Exp Ther 235:657–664
Pöch G (1971) Assay of phosphodiesterase with radioactively labeled cyclic 3′,5′-AMP as substrate. Naunyn-Schmiedeberg's Arch Pharmacol 268:272–299
Pöch G, Kukovetz WR (1971) Papaverine-induced inhibition of phosphodiesterase activity in various mammalian tissues. Life Sci 10:133–144
Rall TW, Sutherland EW (1958) Formation of a cyclic adenine ribonucleotide by tissue particles. J Biol Chem 232:1065–1076
Reinhardt D, Roggenbach W, Brodde O-E, Schumann HJ (1977) Influence of papaverine and isopreinaline on contractility and cyclic AMP level of left guinea-pig atria at different rates of beat. Naunyn-Schmiedeberg's Arch Pharmacol 299:9–15
Robberecht P, Delhaye M, Taton G, De Neef P, Waelbroeck M, De Smet JM, Leclerc JL, Chatelain P, Christophe J (1983) The human heart beta-adrenergic receptors. I. Heterogeneity of the binding sites: presence of 50% beta1- and 50% beta2-adrenergic receptors. Mol Pharmacol 24:169–173
Scholz H (1980) Effects of beta- and alpha-adrenoceptor activators and adrenergic transmitter releasing agents on the mechanical activity of the heart. In: Szekeres L (ed) Handbook of experimental pharmacology, vol 54. Adrenergic activators and inhibitors. Springer, Berlin Heidelberg New York, pp 651–733
Schümann HJ, Endoh M, Brodde O-E (1975) The time course of the effects of β- and α-adrenoceptor stimulation by isoprenaline and methoxamine on contractile force and cAMP level of the isolated rabbit papillary muscle. Naunyn-Schmiedeberg's Arch Pharmacol 289:291–302
Schwabe U, Ebert R (1972) Different effects of lipolytic hormones and phosphodiesterase inhibitors on cyclic 3′,5′-AMP levels in isolated fat cells. Naunyn-Schmiedeberg's Arch Pharmacol 274:287–298
Stephenson RP (1956) A modification of receptor theory. Br J Pharmacol 11:379–393
Stiles GL, Taylor S, Lefkowitz RJ (1983) Human cardiac beta-adrenergic receptors: subtype heterogeneity delineated by direct radioligand binding. Life Sci 33:467–473
Sutherland EW, Robison GA, Butcher RW (1968) Some aspects of the biological role of adenosine 3′,5′-monophosphate (cyclic AMP). Circulation 37:279–306
Tsien RW (1977) Cyclic AMP and contractile activity in heart. In: Greengard P, Robison GA, (ed) Advances in cyclic nucleotide research, vol. 8. Raven, New York, pp 363–420
Venter JC, Ross J, Jr, Kaplan NO (1975) Lack of detectable change in cyclic AMP during cardiac isotropic response to isoproterenol immobilized on glass beads. Proc Natl Acad Sci USA 72:824–828
Waelbroeck M, Taton G, Delhaye M, Chatelain P, Camus JC, Pochet R, Leclerc JL, De Smet JM, Robberecht P, Christophe J (1983) The human heart beta-adrenergic receptors. II. Coupling of beta2-adrenergic receptors with the adenylate cyclase system. Mol Pharmacol 24:174–182
Wagner J, Brodde O-E (1978) On the presence and distribution of α-adrenoceptors in the heart of various mammalian species. Naunyn-Schmiedeberg's Arch Pharmacol 302:239–254
Wang XL, Brinkmann M, Brodde O-E (1985) Selective labelling of β1-adrenoceptors in rabbit lung membranes by (−)[3H] bisoprolol. Eur J Pharmacol 114:157–165
Wilson C, Lincoln C (1984) β-Adrenoceptor subtypes in human, rat, guinea-pig, and rabbit atria. J Cardiovasc Pharmacol 6:1216–1221
Yabuuchi Y (1977) The β-adrenoceptor stimulant properties of OPC-2009 on guinea-pig isolated tracheal, right atrial and left atrial preparations. Br J Pharmacol 61:513–521
Zerkowski H-R, Ikezono K, Rohm N, Reidemeister JChr, Brodde O-E (1986) Human myocardial β-adrenoceptors: demonstration of both β1- and β2-adrenoceptors mediating contractile responses to β-agonists on the isolated right atrium. Naunyn-Schmiedeberg's Arch Pharmacol 332:142–147
Author information
Authors and Affiliations
Additional information
Send offprint requests to O.-E. Brodde at the above address
Rights and permissions
About this article
Cite this article
Ikezono, K., Michel, M.C., Zerkowski, H.R. et al. The role of cyclic AMP in the positive inotropic effect mediated by β1- and β2-adrenoceptors in isolated human right atrium. Naunyn-Schmiedeberg's Arch Pharmacol 335, 561–566 (1987). https://doi.org/10.1007/BF00169125
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00169125